Promino Announces Proposed Private Placement
Burlington, Ontario--(Newsfile Corp. - March 13, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company") announces that it intends to complete a non-brokered private placement for aggregate gross proceeds of up to $1,200,000 through the issuance of up to 40,000,000 units of the Company ("Units") at a price of $0.03 per Unit (the "Offering"). Each Unit will consist of one common share (each, a "Share") and one half of one common share purchase
Aliments / boissons, Sports, Santé
2026-03-13 5:30 PM EDT | Promino Nutritional Sciences, Inc.
Numinus Wellness Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 13, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update. Corporate Update Over the past year, Numinus has undertaken a strategic transformation to streamline its operations and focus on its core
2026-03-13 5:00 PM EDT | Numinus Wellness Inc.
BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its Board of Directors has approved the grant of long-term incentive ("LTI") awards to employees, officers and directors under the Company's equity incentive plan. These
Biotechnologies, Pharmaceutique, Santé
2026-03-13 4:53 PM EDT | BioHarvest Sciences Inc.
Safe Supply Streaming Co Ltd. Announces Annual General and Special Meeting of Shareholders to Be Held on April 8, 2026
Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or the "Company") announces that it will hold its Annual General and Special Meeting of Shareholders (the "Meeting") on Wednesday, April 8, 2026, at 11:00 a.m. (Toronto time) at the offices of Garfinkle Biderman LLP, 1 Adelaide Street East, 8th Floor, Suite 801, Toronto, Ontario M5C 2V9. The Meeting has been called to addres
2026-03-13 7:06 AM EDT | Altrova Health Inc.
Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026
Singapore, Singapore--(Newsfile Corp. - March 12, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI HealthTech platform, today announced that, for the first six months of fiscal 2026 ended December 31, 2025, the Company achieved significant improvements in its gross margin and cash position while slashing its total operating expenses and net loss. Gross margin for the first half of fiscal 2026 was 20.1 percent, compared with 14.
2026-03-12 8:30 AM EDT | Mobile-health Network Solutions
Aleen Inc. Advances Work Toward Web Integration of Personal Account
Toronto, Ontario--(Newsfile Corp. - March 12, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, announces ongoing work to bring its Personal Wellness Account environment to the web, building on prior advancements in Wellness AI Agents and Personal Wellness Account development. Current efforts are focused on exploring options and identifying optimal solutions for a first test version, moving steadily toward a point where users will soon be able to access and experience
2026-03-12 8:17 AM EDT | Aleen Inc.
Rise Nano Optics to Commence Trading on the Canadian Securities Exchange Under the Symbol "EYE", Today, March 12, 2026
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company") is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"). Trading is expected to commence on the CSE under the symbol "EYE" at the open of markets on March 12, 2026. Inas Said, CEO of Rise commented, "Listing publicly r
2026-03-12 7:00 AM EDT | Rise Nano Optics Ltd.
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H0) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, today announced that BioGene Therapeutics Inc. (the "Company"), a company that it is a significant shareholder of, has appointed Raj S. Pruthi, MD, MHA, FACS, as a Director of the Company.
Biotechnologies, Pharmaceutique, Santé
2026-03-12 3:00 AM EDT | PreveCeutical Medical Inc.
Cosmo Presents Agenda for AGM 2026
Dublin, Ireland--(Newsfile Corp. - March 12, 2026) - Cosmo Pharmaceuticals N.V. (“Cosmo”) is pleased to announce the convening of its upcoming Ordinary Annual General Meeting of Shareholders (AGM) to be held on 10 April 2026 in Amsterdam. The agenda includes, among others, the following discussion and voting items: Report of the Board of Directors on the business year 2025 and the ESG achievements Appropri
Soins de santé et hôpitaux, Santé
2026-03-12 1:58 AM EDT | Cosmo Pharmaceuticals N.V.
Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94
Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is excited to announce that it has entered into a non-binding memorandum of terms (the "Term Sheet") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together,
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-03-11 8:54 AM EDT | Psyched Wellness Ltd.
Restart Life Highlights Certified Manufacturing Platform to Drive Margin Expansion and Distribution Growth
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide investors with an update on the strategic value of the Holy Crap™ manufacturing facility and its role in supporting scalable growth, margin expansion, and broader market distribution across the Company's functional wellness portfolio. The Holy Crap™ production facility operates under mul
Technologies, Biotechnologies, Santé
2026-03-11 8:00 AM EDT | Restart Life Sciences Corp.
RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering natural psilocybin manufacturing and formulation Combines Red Light's operational scale, global brand presence, and real-world microdosing data with Filament's pharmaceutical R&D capabilities and patented PEX010 botanical psilocybin drug candidate All-share t
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-03-11 7:30 AM EDT | Red Light Holland Corp.
TempraMed's Independently Validated Payer ROI Model for Reimbursement Further Reinforced by a Scientific Publication Highlighting Clinical and Economic Rationale for VIVI Cap
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, today announced the publication of a clinical case report evaluating the use of VIVI Cap™ for passive thermal protection of insulin during summer travel. The paper, titled "Passive Thermal Protection
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-03-11 7:00 AM EDT | TempraMed Technologies Ltd.
Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering natural psilocybin manufacturing and formulation Combines Red Light's operational scale, global brand presence, and real-world microdosing data with Filament's pharmaceutical R&D capabilities and patented PEX010 botanical psilocybin drug candidate All-share t
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-03-10 4:40 PM EDT | Red Light Holland Corp.
Orange Auto Insurance, Inc., subsidiary of HPN Holdings, Inc. Secures Fronting Carrier Partnership to Launch Innovative Auto Insurance Program
Chicago, Illinois--(Newsfile Corp. - March 10, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or the "Company") today announced that its subsidiary Orange Auto Insurance, Inc ("Orange"), a managing general agency focused on delivering technology-driven automobile insurance solutions, has agreed to terms with a highly rated fronting carrier to support the launch of its new auto insurance program. The partnership marks a significant milestone for the company as it prepares to bring its product
2026-03-10 9:00 AM EDT | HPN Holdings, Inc.
Safe Supply Streaming Co Ltd. Achieves U.S. Federal Vendor Registration and Secures Municipal Vendor Approval in Boca Raton, Florida
Toronto, Ontario--(Newsfile Corp. - March 10, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or the "Company") is pleased to announce that its wholly owned subsidiary, Safety Strips Tech Corp. ("Safety Strips"), has obtained a Unique Entity Identifier ("UEI") through the United States Government's System for Award Management (SAM.gov) and has received approved vendor status with the City of Boca Raton, Florida.
2026-03-10 7:03 AM EDT | Altrova Health Inc.
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
King of Prussia, Pennsylvania--(Newsfile Corp. - March 10, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on March 12th
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-03-10 7:00 AM EDT | Phio Pharmaceuticals Corp.
Hemostemix Leadership Attending Abundance360 Summit
Calgary, Alberta--(Newsfile Corp. - March 9, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) today announced that Thomas Smeenk CEO and Peter Lacey, Chairman are attending the 2026 Abundance360 Summit in Los Angeles this week. Founded by futurist and entrepreneur Peter H. Diamandis, the annual Abundance360 Summit convenes leading entrepreneurs, and investors, working at the frontiers of biotechnology, artificial intelligence, longevity science, and other exponential techn
Biotechnologies, Pharmaceutique, Santé
2026-03-09 11:23 AM EDT | Hemostemix Inc.
Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies
Orlando, Florida--(Newsfile Corp. - March 9, 2026) - Adia Nutrition's (OTCQB: ADIA) subsidiary, Adia Med, has launched a complete digital refresh of its online presence. Through a strategic partnership with ZenChange Marketing, Adia Med has relaunched its website with a modern, streamlined design focused on transparency, accessibility, and clear information about its investigational studies. The update makes it easier for families, researchers, and healthcare professionals to explore the orga
Soins de santé et hôpitaux, Santé
2026-03-09 9:38 AM EDT | Adia Nutrition Inc.
Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000
Montreal, Quebec--(Newsfile Corp. - March 9, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the closing of a private placement (the "Private Placement") of 17,445,455 units (the "Units") at a price of $0.55 per Unit, for aggregate gross proceeds to Defence of $9,595,000.25. Each Unit is comprised
Biotechnologies, Pharmaceutique, Santé
2026-03-09 3:15 AM EDT | Defence Therapeutics Inc.